Cargando…
PDG17 Adverse Drug Reactions Associated to Hydroxychloroquine and Remdesivir in COVID-19 Patients: Analysis of Reported ADR to the Portuguese Pharmacovigilance System
| Autores principales: | , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Published by Elsevier Inc.
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8177613/ http://dx.doi.org/10.1016/j.jval.2021.04.465 |
| _version_ | 1783703418212188160 |
|---|---|
| author | Ivos, R. Ribeiro-Vaz, I. Polónia, J. Silva, A. |
| author_facet | Ivos, R. Ribeiro-Vaz, I. Polónia, J. Silva, A. |
| author_sort | Ivos, R. |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-8177613 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2021 |
| publisher | Published by Elsevier Inc. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-81776132021-06-05 PDG17 Adverse Drug Reactions Associated to Hydroxychloroquine and Remdesivir in COVID-19 Patients: Analysis of Reported ADR to the Portuguese Pharmacovigilance System Ivos, R. Ribeiro-Vaz, I. Polónia, J. Silva, A. Value Health Article Published by Elsevier Inc. 2021-06 2021-06-04 /pmc/articles/PMC8177613/ http://dx.doi.org/10.1016/j.jval.2021.04.465 Text en Copyright © 2021 Published by Elsevier Inc. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
| spellingShingle | Article Ivos, R. Ribeiro-Vaz, I. Polónia, J. Silva, A. PDG17 Adverse Drug Reactions Associated to Hydroxychloroquine and Remdesivir in COVID-19 Patients: Analysis of Reported ADR to the Portuguese Pharmacovigilance System |
| title | PDG17 Adverse Drug Reactions Associated to Hydroxychloroquine and Remdesivir in COVID-19 Patients: Analysis of Reported ADR to the Portuguese Pharmacovigilance System |
| title_full | PDG17 Adverse Drug Reactions Associated to Hydroxychloroquine and Remdesivir in COVID-19 Patients: Analysis of Reported ADR to the Portuguese Pharmacovigilance System |
| title_fullStr | PDG17 Adverse Drug Reactions Associated to Hydroxychloroquine and Remdesivir in COVID-19 Patients: Analysis of Reported ADR to the Portuguese Pharmacovigilance System |
| title_full_unstemmed | PDG17 Adverse Drug Reactions Associated to Hydroxychloroquine and Remdesivir in COVID-19 Patients: Analysis of Reported ADR to the Portuguese Pharmacovigilance System |
| title_short | PDG17 Adverse Drug Reactions Associated to Hydroxychloroquine and Remdesivir in COVID-19 Patients: Analysis of Reported ADR to the Portuguese Pharmacovigilance System |
| title_sort | pdg17 adverse drug reactions associated to hydroxychloroquine and remdesivir in covid-19 patients: analysis of reported adr to the portuguese pharmacovigilance system |
| topic | Article |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8177613/ http://dx.doi.org/10.1016/j.jval.2021.04.465 |
| work_keys_str_mv | AT ivosr pdg17adversedrugreactionsassociatedtohydroxychloroquineandremdesivirincovid19patientsanalysisofreportedadrtotheportuguesepharmacovigilancesystem AT ribeirovazi pdg17adversedrugreactionsassociatedtohydroxychloroquineandremdesivirincovid19patientsanalysisofreportedadrtotheportuguesepharmacovigilancesystem AT poloniaj pdg17adversedrugreactionsassociatedtohydroxychloroquineandremdesivirincovid19patientsanalysisofreportedadrtotheportuguesepharmacovigilancesystem AT silvaa pdg17adversedrugreactionsassociatedtohydroxychloroquineandremdesivirincovid19patientsanalysisofreportedadrtotheportuguesepharmacovigilancesystem |